Cargando…
1579. Burkholderia Returns: Are Two Drugs Better or Back to Bactrim?
BACKGROUND: Trimethoprim-sulfamethoxazole (T/S) and levofloxacin are considered first line agents for the treatment of Burkholderia cepacia complex (Bcc). Combination therapy (CT) is frequently utilized despite limited clinical evidence supporting this. The objective of this study is to compare outc...
Autores principales: | Hedvat, Jason, Kubin, Christine J, Mehta, Monica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777867/ http://dx.doi.org/10.1093/ofid/ofaa439.1759 |
Ejemplares similares
-
1578. Back to Bactrim–Utilizing Preferred Prophylaxis Strategies in Immunocompromised Hosts Via a Trimethoprim-Sulfamethoxazole Rechallenge Program
por: Smibert, Olivia, et al.
Publicado: (2018) -
The efficacy of bactrim in reducing surgical site infections after spine surgery
por: Choi, Jeffrey Hyun-Kyu, et al.
Publicado: (2021) -
Relación de Misantla: 1579
por: Pérez de Arteaga, Diego
Publicado: (2018) -
P1579: PHOTOBIOMODULATION FOR CHEMOTHERAPY-INDUCED ORAL MUCOSITIS IN LEUKEMIC CHILDREN: A RANDOMIZED CONTROLLED CLINICAL TRIAL
por: El Chazli, Y., et al.
Publicado: (2022) -
1579. Incidence and Predicting Factors of Opportunistic Infections after Initiation of Antiretroviral Therapy: A Retrospective Cohort Study
por: Wongkittipong, Prapon, et al.
Publicado: (2023)